S100B protein as a possible participant in the brain metastasis of NSCLC

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2626-2632

  Pang, Xiaowen ^a   Min, Jie ^a   Liu, Lili ^a   Liu, Yi ^a   Ma, Ningqiang ^a   Zhang, Helong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brain metastasis; Invasion; Migration; Non small cell lung cancer; Proliferation; S100B

Indexed keywords

PROTEIN S100B;

APOPTOSIS; ARTICLE; BRAIN METASTASIS; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

APOPTOSIS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 84867992442     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0169-0     Document Type: Article

References (34)

1. Mulvenna PM. The management of brain metastases in patients with non-small cell lung cancer-is it time to go back to the drawing board? Clin Oncol (R Coll Radiol). 2010;22(5):365-73.
2. Soffietti R, Ruda R, Mutani R. Management of brain metastases. J Neurol. 2002;249(10):1357-69.
3. Thomas SS, Dunbar EM. Modern multidisciplinary management of brain metastases. Curr Oncol Rep. 2010;12(1):34-40.
4. Villa S, Weber DC, Moretones C, Manes A, Combescure C, Jove J, Puyalto P, Cuadras P, Bruna J, Verger E, Balana C, Graus F. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study. Radiat Oncol. 2011;6:23.
5. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 1981;48(2):384-94.
6. Sundstrom JT, Minn H, Lertola KK, Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med. 1998;30(3):296-9.
7. Kelly K, Bunn PA Jr. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? Lung Cancer. 1998;20(2):85-91.
8. Hoseok I, Lee JI, Nam DH, Ahn YC, Shim YM, Kim K, Choi YS, Kim J. Surgical treatment of non-small cell lung cancer with isolated synchronous brain metastases. J Korean Med Sci. 2006;21(2):236-41.
9. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33(7):637-68.
10. Goncalves CA, Leite MC, Guerra MC. Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc Psychiatry Neurol. 2010;2010:790431.
11. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002;7:d1356-68.
12. Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I, Donato R. The many faces of S100B protein: when an extracellular factor inactivates its own receptor and activates another one. Ital J Anat Embryol. 2010;115(1-2):147-51.
13. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta. 2009;1793(6):1008-22.
14. Smith SP, Shaw GS. A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form. Structure. 1998;6(2):211-22.
15. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Techniq. 2003;60(6):540-51.
16. Sorci G, Bianchi R, Riuzzi F, Tubaro C, Arcuri C, Giambanco I, Donato R (2010) S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond. Cardiovasc Psychiatry Neurol. doi: 10.1155/2010/656481.
17. Lin J, Yang Q, Wilder PT, Carrier F, Weber DJ. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem. 2010;285(35):27487-98.
18. Li Y, Barger SW, Liu L, Mrak RE, Griffin WS. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. J Neurochem. 2000;74(1):143-50.
19. Lam AG, Koppal T, Akama KT, Guo L, Craft JM, Samy B, Schavocky JP, Watterson DM, Van Eldik LJ. Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol Aging. 2001;22(5):765-72.
20. Hu J, Ferreira A, Van Eldik LJ. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem. 1997;69(6):2294-301.
21. Bouwhuis MG, Suciu S, Kruit W, Sales F, Stoitchkov K, Patel P, Cocquyt V, Thomas J, Lienard D, Eggermont AM, Ghanem G. Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952. Eur J Cancer. 2011;47(3):361-8.
22. Janigro D, Vogelbaum MA, Masaryk T, Mazzone P, Mekhail T, Fazio V, McCartney S, Marchi N, Kanner A. S100 beta as a predictor of brain metastases-Brain versus cerebrovascular damage. Cancer. 2005;104(4):817-24.
23. Hu L, Zhang J, Zhu H, Min J, Feng Y, Zhang H. Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma. Med Oncol. 2010;27(3):708-14.
24. Sul J, Posner JB. Brain metastases: epidemiology and pathophysiology. Cancer Treat Res. 2007;136:1-21.
25. Carbonell WS, Ansorge O, Sibson N, Muschel R. The vascular basement membrane as soil in brain metastasis. Plos One. 2009;4(6):e5857.
26. Zhang C, Yu D. Microenvironment determinants of brain metastasis. Cell Biosci. 2011;1(1):8.
27. Nathoo N, Chahlavi A, Barnett GH, Toms SA. Pathobiology of brain metastases. J Clin Pathol. 2005;58(3):237-42.
28. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98-101.
29. Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, Janigro D. Peripheral markers of blood-brain barrier damage. Clin Chim Acta. 2004;342(1-2):1-12.
30. Kapural M, Krizanac-Bengez L, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussen P, Mayberg MR, Janigro D. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 2002;940(1-2):102-4.
31. Lin J, Blake M, Tang C, Zimmer D, Rustandi RR, Weber DJ, Carrier F. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J Biol Chem. 2001;276(37):35037-41.
32. Rustandi RR, Baldisseri DM, Weber DJ. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol. 2000;7(7):570-4.
33. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Natl Rev Mol Cell Biol. 2008;9(5):402-12.
34. Selinfreund RH, Barger SW, Welsh MJ, Van Eldik LJ. Antisense inhibition of glial S100 beta production results in alterations in cell morphology, cytoskeletal organization, and cell proliferation. J Cell Biol. 1990;111(5 Pt 1):2021-8.